APOE and Alzheimer disease: Heterozygosity of the APOE ε4 allele confers a 3–4-fold increase of AD risk and ε4 homozygotes have a 10–12-fold increased likelihood of a clinical diagnosis of AD among persons of European ancestry [9, 11].